Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...

Plus the list of biosimilars approved by the FDA ... Widespread adoption of biosimilar drugs could multiply these savings across global healthcare systems, huge cost savings.

Prescription drugs prices have rapidly increased, but opting for generic medications and incorporating lifestyle changes are some ways to cut costs.

Chicago, IL – June 10, 2025 – Today, Zacks Equity Research discusses Sandoz SDZNY, Teva Pharmaceuticals TEVA and Viatris VTRS ...

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

Switching to Humira biosimilars saved Navitus clients more than $315 million in upfront costs in 2024 and resulted in a 60% ...

President Donald J. Trump has signaled that lowering the costs of prescription drugs will be a priority for his second term.

Across brand drugs, pharmacy list prices are 422 percent higher in ... the patent thickets that slow to a crawl any generic and biosimilar competition from entering the market to compete with ...

Johnson & Johnson JNJ has one of the most diverse revenue streams in the industry within the pharmaceutical division called ...